Aeglea BioTherapeutics, Inc. has been dropped from Nasdaq Composite Index.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
37.38 USD | -4.86% | +13.20% | +73.70% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+73.70% | 158.26Cr | |
+7.52% | 11TCr | |
+11.38% | 11TCr | |
-12.64% | 2.22TCr | |
+0.44% | 2.13TCr | |
-4.18% | 1.9TCr | |
-37.85% | 1.85TCr | |
-8.58% | 1.68TCr | |
+37.41% | 1.25TCr | |
-23.95% | 808.97Cr |
- Stock Market
- Equities
- SYRE Stock
- News Spyre Therapeutics, Inc.
- Spyre Therapeutics, Inc.(NasdaqCM: SYRE) dropped from NASDAQ Composite Index